Epidermal growth factor receptor |
Peptide-targeted gold nanoparticles |
Pc 4 |
Brain cancer |
Photodynamic therapy |
[213] |
Epidermal growth factor receptor |
PLGA nanoparticles |
Tylocrebine |
Several types of tumors, including epidermoid cancer |
Chemotherapy |
[214] |
Fibrin-associated plasma proteins |
CREKA-conjugated dextran-coated iron oxide nanoparticles |
Iron oxide NPs |
Non-small lung cancer |
Hyperthermia |
[67] |
Fibrin-associated plasma proteins |
CREKA-conjugated liposomes |
Doxorubicin |
Breast cancer |
Chemotherapy |
[68] |
Folate receptors |
PLGA polymeric nanoparticles |
Doxorubicin |
Breast cancer |
Chemotherapy |
[47] |
Folate receptors |
Cobalt ferrite nanoparticles |
Hematoporphyrin |
Several types of FR-positive tumors |
Photodynamic therapy |
[65] |
Folate receptors |
Deoxycholic acid-O-carboxymethylated chitosan nanoparticles |
Paclitaxel |
Breast cancer |
Chemotherapy |
[25] |
IL-13Rɑ2 |
Liposomes |
Doxorubicin |
Glioblastoma multiforme |
Chemotherapy |
[215] |
Integrin receptors |
RGD-modified liposomes |
Paclitaxel |
Hepatocellular carcinoma |
Chemotherapy |
[216] |
LHRH receptor |
Gold nanorods |
Goserelin |
Prostate cancer |
Radiotherapy |
[217] |
Transferrin receptors |
PEGylated gold nanoparticles |
AuNPs |
Mouse neuroblastoma |
Chemotherapy |
[61] |
Transferrin receptors |
VitE TPGS-encapsulated micelles |
Docetaxel |
Breast cancer |
Chemotherapy |
[34] |
Transferrin receptors |
PLGA polymeric nanoparticles |
Methotrexate |
Brain cancer |
Chemotherapy |
[33] |